July 26, 2024 – BD and Quest Diagnostics introduced a worldwide collaboration settlement to develop, manufacture and commercialize stream cytometry-based companion diagnostics (CDx) instruments to assist choose the most effective remedy for sufferers with most cancers and different illnesses.

Collectively, BD and Quest will present the pharmaceutical trade with an end-to-end answer for CDx improvement. The joint choices will vary from the event of exploratory panels to the manufacturing and distribution of FDA-approved diagnostic kits.

Utilizing companion diagnostics to assist choose first-line remedy for most cancers sufferers may be vital to making sure the most effective outcomes and price financial savings. In the present day’s companion diagnostic exams sometimes incorporate applied sciences akin to immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), polymerase chain response (PCR), next-generation sequencing (NGS), and imaging. Stream cytometry, a longtime laboratory expertise now being utilized to the event of companion diagnostics, can quickly analyze and type particular person cells to allow healthcare suppliers to grasp a person’s immune response and may present perception into the right way to greatest deal with the affected person to enhance scientific outcomes.

Discover out extra